AT2 but not AT1 receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats-Reference-Cited by-同舟云学术

AT2 but not AT1 receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats

Published:2002-04 Issue:1-2 Volume:131 Page:79-86
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Braszko Jan J

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference40 articles.

1. Retention of a passive avoidance responses as a function of the intensity and duration of electric shock;Ader;Psychon. Sci.,1972

2. Angiotensin receptors in the nervous system;Allen;Brain Res. Bull.,1998

3. Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats;Baranowska;Psychopharmacology,1983

4. Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract;Boscan;Neuroscience,2001

5. Braszko JJ. AT1 angiotensin receptor blockade abolishes improvement of recall and recognition memory but not facilitation of the conditioned avoidance responses caused by the peptide, Behav Pharmacol 2001 (in press).

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Some Modulators of the Renin–Angiotensin System on the Scopolamine-Induced Memory Loss Mice Model;Brain Sciences;2023-08-16

2. How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis;Frontiers in Psychiatry;2020-11-16

3. Angiotensin II Type 2 Receptor–Expressing Neurons in the Central Amygdala Influence Fear-Related Behavior;Biological Psychiatry;2019-12

4. A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice;American Journal of Alzheimer's Disease & Other Dementias®;2019-05-19

5. Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia;Journal of Internal Medicine;2018-10-28